Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,697 | -25,967 | -20,161 | -12,612 | -6,408 |
| Depreciation Amortization | 35 | 240 | 159 | 110 | 61 |
| Accounts payable and accrued liabilities | 13 | -157 | -591 | -1,315 | 278 |
| Other Working Capital | -1,631 | -1,050 | -448 | -1,183 | -681 |
| Other Operating Activity | 315 | 1,342 | 685 | 1,332 | 175 |
| Operating Cash Flow | $-7,965 | $-25,592 | $-20,356 | $-13,668 | $-6,575 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 872 | 38,497 | 32,703 | 14,364 | N/A |
| Other Financing Activity | -1 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $871 | $38,497 | $32,703 | $14,364 | $N/A |
| Beginning Cash Position | 21,619 | 8,714 | 8,714 | 8,714 | 8,714 |
| End Cash Position | 14,525 | 21,619 | 21,061 | 9,410 | 2,139 |
| Net Cash Flow | $-7,094 | $12,905 | $12,347 | $696 | $-6,575 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,965 | -25,592 | -20,356 | -13,668 | -6,575 |
| Free Cash Flow | -7,965 | -25,592 | -20,356 | -13,668 | -6,575 |